Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials.
Lancet Oncol
; 21(2): 271-282, 2020 02.
Article
in En
| MEDLINE
| ID: mdl-31838007
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Benzamides
/
Biomarkers, Tumor
/
Receptors, Nerve Growth Factor
/
Protein Kinase Inhibitors
/
Gene Fusion
/
Indazoles
/
Neoplasms
/
Antineoplastic Agents
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Lancet Oncol
Journal subject:
NEOPLASIAS
Year:
2020
Document type:
Article
Affiliation country:
United States
Country of publication:
United kingdom